C12N 2750/10011
Circoviridae
C12N2750/10011 (Circoviridae) appears on 253 US grants and 348 published applications in this corpus.
Search patents in C12N- Granted patents
- 253
- Published applications
- 348
- Assignees
- 112
- Inventors
- 483
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 1 | 0 |
| 2001 | 7 | 1 |
| 2002 | 4 | 9 |
| 2003 | 6 | 8 |
| 2004 | 3 | 12 |
| 2005 | 3 | 11 |
| 2006 | 5 | 11 |
| 2007 | 15 | 15 |
| 2008 | 12 | 20 |
| 2009 | 8 | 19 |
| 2010 | 18 | 27 |
| 2011 | 8 | 24 |
| 2012 | 3 | 8 |
| 2013 | 6 | 16 |
| 2014 | 7 | 12 |
| 2015 | 15 | 21 |
| 2016 | 10 | 16 |
| 2017 | 22 | 23 |
| 2018 | 25 | 13 |
| 2019 | 9 | 14 |
| 2020 | 15 | 15 |
| 2021 | 12 | 10 |
| 2022 | 5 | 10 |
| 2023 | 7 | 9 |
| 2024 | 7 | 10 |
| 2025 | 5 | 8 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2750/10034Use of virus or viral component as vaccineIndexing code205
- C12N 2750/10022New viral proteins or individual genes, new structural or functional aspects ofIndexing code139
- C12N 2750/10051Methods of production or purification of viral materialIndexing code71
- C12N 2750/10021Viruses as suchIndexing code64
- C12N 2750/10061Methods of inactivation or attenuationIndexing code51
- C12N 2750/10071Demonstrated in vivo effectIndexing code31
- C12N 2750/10041Use of virus, viral particle or viral elements as a vectorIndexing code27
- C12N 2750/10023Virus like particles [vlp]Indexing code20
All 12 subgroupsShow fewer
Recent patents
- M Hyo multivalent vaccine and uses thereof16 Jun 2026US 12,653,876 B2
- Prostate targeting adeno-associated virus serotype vectors26 May 2026US 12,636,382 B2University of Massachusetts
- Combination of vaccines to prophylactically treat a pig7 Apr 2026US 12,594,328 B2Intervet Inc.
- Porcine circovirus type 2 VLP vaccine6 Jan 2026US 12,514,916 B2Meiji Animal Health Co., Ltd.
- Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof7 Oct 2025US 12,433,942 B2
- Compositions and methods including rna-binding proteins24 Sep 2026US 2026/0286325 A1Regents of the University of Minnesota
- Method of producing an immunogenic composition30 Jul 2026US 2026/0216312 A1Boehringer Ingelheim Animal Health USA Inc.
- Oil adjuvant compositions and vaccine emulsions comprising such oil adjuvant compositions23 Jul 2026US 2026/0207737 A1Ceva Sante Animale
- Methods and compositions of quaternary immunomodulatory nanoparticles for medical applications and immunotherapy25 Jun 2026US 2026/0174841 A1
- Identification of a human circovirus4 Jun 2026US 2026/0152812 A1
Most cited
By later US patents
- Porcine circovirus and paravovirus vaccine105US 6,217,883 B1Merial Limited · 2001
- Porcine circoviruses vaccines diagnostic reagents105US 6,391,314 B1Merial Limited · 2002
- Porcine circovirus vaccine and diagnostics reagents99US 6,368,601 B1Merial Limited · 2002
- Porcine circovirus recombinant poxvirus vaccine87US 6,497,883 B1Merial Limited · 2002
- Vaccines against circovirus infections85US 6,287,856 B1University of Georgia Research Foundation, Inc. · 2001